KELONIA
Live / Registered — Registered (as of 27 Jan 2026)
What this means for you
Registered since 27 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97111463
- Registration number
- 8118607
- Mark type
- Design + words
- Filed
- 05 Nov 2021
- Published for opposition
- 06 Dec 2022
- Registered
- 27 Jan 2026
- Attorney of record
- John L. DuPre'
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medical preparations for use in cell and gene therapy for treatment of cancer and genetic diseases; Gene therapy and viral vectors for treatment of cancer and genetic diseases
Owner
- KELONIA THERAPEUTICS, INC., Boston, MA, US
- KELONIA THERAPEUTICS, INC., Boston, MA, US
- KELONIA THERAPEUTICS, INC., BOSTON, WA, US
- Viralogic Therapeutics, Inc., Boston, MA, US
Prosecution history
- 27 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 08 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Nov 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 19 May 2025 — USE AMENDMENT FILED
- 12 Nov 2025 — SOU EXTENSION 5 GRANTED
- 30 Jul 2025 — SOU EXTENSION 5 FILED
- 12 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 19 May 2025 — TEAS STATEMENT OF USE RECEIVED
- 09 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Dec 2024 — SOU EXTENSION 4 GRANTED
- 06 Dec 2024 — SOU EXTENSION 4 FILED